Margaret R Schlesinger is a Seattle, Washington based female rheumatologist who is specialized in Rheumatology. Active license number of Margaret R Schlesinger is MD00016950 in Washington. Margaret R Schlesinger treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Margaret R Schlesinger speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
4800 Sand Point Way Ne, Seattle, Washington, 98105-3901
Phone:
206-987-2057
Fax:
206-987-5060
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1407803992
NPI Enumeration Date:
28 May, 2006
NPI Last Update On:
03 Feb, 2009
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Margaret R Schlesinger are as mentioned below.
License Number
Specialization
State
Status
MD00016950
Washington
Primary
MD00016950
Rheumatology
Washington
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 50010, Seattle, Washington
Zip:
98105-1010
Phone Number:
206-987-8450
Fax Number:
206-987-8484
Patients can reach Margaret R Schlesinger at 4800 Sand Point Way Ne, Seattle, Washington or can call to book an appointment on 206-987-2057. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.